Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 8
Submit an article Journal homepage
379
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

RETRACTED ARTICLE: Thalidomide analog CC-122 induces a refractory state in monocytes from patients with diffuse large B cell lymphoma

Carolina Cubillos-ZapataTumor Immunology Laboratory, IdiPAZ, Madrid, Spain; ;Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; ;Center for Biomedical Research Network, CIBEres, Madrid, Spain;
,
Raúl CórdobaLymphoma Unit, Oncohealth Institute and Health Research Institute IIS-FJS-Autonomous University of Madrid, Madrid, Spain; ;START Madrid FJD, Phase 1 Clinical Trials Unit, Foundation Jiménez Díaz University Hospital, Madrid, Spain
,
Jose Avendaño-OrtizTumor Immunology Laboratory, IdiPAZ, Madrid, Spain; ;Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; ;Center for Biomedical Research Network, CIBEres, Madrid, Spain;
&
Eduardo Lopez-CollazoTumor Immunology Laboratory, IdiPAZ, Madrid, Spain; ;Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; ;Center for Biomedical Research Network, CIBEres, Madrid, Spain; Correspondence[email protected]
Pages 1999-2001 | Received 19 Oct 2016, Accepted 09 Dec 2016, Published online: 16 Jan 2017

References

  • Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117:5019–5032.
  • Hitz F, Connors JM, Gascoyne RD, et al. Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment. Ann Hematol. 2015;94:1839–1843.
  • Hagner PR, Man HW, Fontanillo C, et al. CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL. Blood. 2015;126:779–789.
  • Cubillos-Zapata C, Códoba R, Avendaño-Ortiz J, et al. CC-122 Immunomodulatory effects in refractory patients with diffuse large B-cell lymphoma. Oncoimmunology. 2016. [Epub ahead of print]. doi: 10.1080/2162402X.2016.1231290.
  • del Fresno C, Garcia-Rio F, Gomez-Pina V, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol. 2009;182:6494–6507.
  • Fernandez-Ruiz I, Arnalich F, Cubillos-Zapata C, et al. Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarction. PLoS One. 2014;9:e95073.
  • Jurado-Camino T, Cordoba R, Esteban-Burgos L, et al. Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance. J Immunol. 2015;194:719–727.
  • Monneret G, Venet F, Pachot A, et al. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med. 2008;14:64–78.
  • Lopez-Collazo E, del Fresno C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care. 2013;17:242.
  • Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549–555.
  • Cubillos-Zapata C, Hernandez-Jimenez E, Toledano V, et al. NFkappaB2/p100 is a key factor for endotoxin tolerance in human monocytes: a demonstration using primary human monocytes from patients with sepsis. J Immunol. 2014;193:4195–4202.
  • Marriott JB, Westby M, Cookson S, et al. CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. J Immunol. 1998;161:4236–4243.
  • Corral LG, Haslett PA, Muller GW, et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol. 1999;163:380–386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.